West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
246.95
+1.50 (0.61%)
Aug 29, 2025, 4:00 PM - Market closed
WST Stock Forecast
Stock Price Forecast
The 6 analysts that cover WST stock have a consensus rating of "Buy" and an average price target of $332.5, which forecasts a 34.64% increase in the stock price over the next year. The lowest target is $245 and the highest is $400.
Price Target: $332.5 (+34.64%)
Analyst Consensus: Buy
* Price targets were last updated on Jul 25, 2025.
Analyst Ratings
The average analyst rating for WST stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $285 → $320 | Strong Buy | Maintains | $285 → $320 | +29.58% | Jul 25, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $275 → $350 | Buy | Maintains | $275 → $350 | +41.73% | Jul 25, 2025 |
| Barclays | Barclays | Hold Initiates $245 | Hold | Initiates | $245 | -0.79% | Jun 24, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $275 | Buy | Initiates | $275 | +11.36% | Mar 18, 2025 |
| Keybanc | Keybanc | Buy Maintains $470 → $325 | Buy | Maintains | $470 → $325 | +31.61% | Feb 14, 2025 |
Financial Forecast
Revenue This Year
3.08B
from 2.89B
Increased by 6.28%
Revenue Next Year
3.26B
from 3.08B
Increased by 6.02%
EPS This Year
6.82
from 6.69
Increased by 1.90%
EPS Next Year
7.60
from 6.82
Increased by 11.52%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.2B | 3.4B | |||
| Avg | 3.1B | 3.3B | |||
| Low | 2.9B | 3.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.1% | 12.1% | |||
| Avg | 6.3% | 6.0% | |||
| Low | 0.3% | -0.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.21 | 8.28 | |||
| Avg | 6.82 | 7.60 | |||
| Low | 6.49 | 7.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.8% | 21.5% | |||
| Avg | 1.9% | 11.5% | |||
| Low | -3.0% | 3.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.